关注肺健康, 实现COPD防治关口前移

王妍; 闫巍

doi:10.16766/j.cnki.issn.1674-4152.003865

关注肺健康, 实现COPD防治关口前移

doi: 10.16766/j.cnki.issn.1674-4152.003865

王妍¹,
闫巍^2, ,

1.
北京市海淀区玉渊潭社区卫生服务中心, 北京 100142
2.
首都医科大学附属复兴医院全科医学科, 北京 100038

基金项目:

首都全科医学研究专项课题 22QK18

详细信息

通讯作者:
闫巍，E-mail：ymyjy5006@sina.com

中图分类号: R563
计量
- 文章访问数: 7
- HTML全文浏览量: 4
- PDF下载量: 1
- 被引次数: 0
出版历程
- 收稿日期: 2024-01-15
- 网络出版日期: 2025-03-27

Prioritizing lung health: Achieving effective prevention and treatment of chronic obstructive pulmonary disease

WANG Yan¹,
YAN Wei^{2
, ,}

1.
Yuyuantan Community Health Service Center, Haidian District, Beijing 100142, China

摘要

摘要: 慢性阻塞性肺疾病(COPD, 简称慢阻肺)是最常见的慢性呼吸系统疾病, 具有高发病率、高致残率、高死亡率的特点, 被认为是世界各地发病率和死亡率的主要原因之一, 给个人、家庭、社会带来沉重的经济负担和照护负担。慢阻肺所带来的沉重疾病负担, 已被广泛认为是一个重要的全球公共卫生问题, 而广泛的诊断不足和误诊导致患者得不到治疗或治疗不当, 更加剧了慢阻肺的防控形势。慢阻肺是一种常见的、可预防和可治疗的疾病, 目前认为早期发现、早期诊断和尽早干预应是慢性阻塞性肺疾病防治的努力方向, 并且可以产生非常积极且显著的公共卫生影响。然而, 随着近年来人口老龄化加剧以及慢阻肺的发病率逐年上升, 当前慢阻肺的全球诊疗现状并不乐观。在我国, 居民对慢阻肺的认知度低下, 基层医务人员对慢阻肺的相关知识和防治技能掌握欠缺, 严重影响了慢阻肺的早期规范化防治。本文叙述了我国慢阻肺防治现状, 提出关注肺健康, 对有慢性咳嗽、气促等呼吸道症状及有慢阻肺高危因素的人群实行早期筛查、早期诊断、早期干预、及时转诊, 与三级综合医院呼吸专科医生协同, 共同完成对其闭环管理, 实现肺部健康, 以期为慢阻肺的早期预防、早期诊断以及及时和适当的治疗干预提供参考并打开新的机会之窗。
- 肺健康 /
- 慢性阻塞性肺疾病 /
- 筛查与管理 /
- 早期
Abstract: Chronic obstructive pulmonary disease (COPD) is the most common chronic respiratory disease. It is characterized by high incidence, disability, and mortality rates. It is considered to be one of the main causes of morbidity and mortality worldwidely. It contributes significantly to the economic and caregiving burdens on individuals, families, and society. The substantial burden of COPD has been widely recognized as a major global public health issue. However, the widespread lack of diagnosis and misdiagnosis lead to many patients either not receiving treatment or receiving inappropriate care, further complicating the prevention and control of COPD. Chronic obstructive pulmonary disease is a common, preventable, and treatable disease. It is currently believed that early detection, diagnosis, and intervention are crucial in the prevention and treatment of COPD, and can lead to significant improvements in public health. However, with the aging population and the increasing incidence of COPD in recent years, the current global diagnosis and treatment of COPD remains concerning. In China, public awareness of chronic obstructive pulmonary disease is low, and primary healthcare providers lack the necessary knowledge and prevention skills related to COPD. This significantly hampers the early, standardized prevention and treatment of COPD. This article discusses the current situation of prevention and treatment of chronic obstructive pulmonary disease in China and advocates for increased attention to lung health. Early screening, diagnosis, and intervention should be carried out for individuals with respiratory symptoms, such as chronic cough and shortness of breath, as well as high-risk factors for COPD. Timely referrals should be made, and in collaboration with respiratory specialists at tertiary hospitals, closed-loop management should be completed to established to ensure optimal lung health. The aim is to provide a framework for early prevention, diagnosis, and timely, appropriate treatment and intervention of COPD, ultimately opening new opportunities for improved care.
- Pulmonary health /
- Chronic obstructive pulmonary disease /
- Screening and management /
- Early phase

HTML全文

参考文献(33)

[1]	Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease 2022 report[EB/OL]. (2021-11-15)[2022-04-18]. https://goldcopd.org/2022-gold-reports/.
[2]	陈典, 隆寰宇, 李姝润, 等. 2024年GOLD慢性阻塞性肺疾病诊断、治疗、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2024, 27(13): 1533-1543. doi: 10.12114/j.issn.1007-9572.2023.0867 CHEN D, LONG H Y, LI S R, et al. Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2024 Report[J]. Chinese General Practice, 2024, 27(13): 1533-1543. doi: 10.12114/j.issn.1007-9572.2023.0867
[3]	GBD Chronic Respiratory Disease Collaborators. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet Respir Med, 2020, 8(6): 585-596. doi: 10.1016/S2213-2600(20)30105-3
[4]	ADELOYE D, SONG P, ZHU Y, et al. Global, regional, and national prevalence of, and risk factors for, chronic obstructive pulmonary disease (COPD) in 2019: a systematic review and modelling analysis[J]. Lancet Respir Med, 2022, 10(5): 447-458. doi: 10.1016/S2213-2600(21)00511-7
[5]	SAFIRI S, CARSON-CHAHHOUD K, NOORI M, et al. Burden of chronic obstructive pulmonary disease and its attributable risk factors in 204 countries and territories, 1990-2019: results from the Global Burden of Disease Study 2019[J]. BMJ, 2022, 378: e069679. DOI: 10.1136/bmj-2021-069679.
[6]	陈亚红. 2020年GOLD慢性阻塞性肺疾病诊断、治疗及预防全球策略解读[J]. 中国医学前沿杂志(电子版), 2019, 11(12): 32-50. CHEN Y H. Interpretation of global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2020 report[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version), 2019, 11(12): 32-50.
[7]	李香荷, 罗青, 唐娜, 等. 1990—2019年中国慢性阻塞性肺疾病死亡负担及变化情况分析[J]. 中国循环杂志, 2023, 38(6): 681-686. LI X H, LUO Q, TANG N, et al. Analysis of the Death Burden and Changes in Chronic Obstructive Pulmonary Disease in China from 1990 to 2019[J]. Chinese Journal of Circulation, 2023, 38(6): 681-686.
[8]	项文勤, 俞浩, 苏健, 等. 2015年与2019年江苏省40岁及以上人群慢性阻塞性肺疾病负担及吸烟归因疾病负担研究[J]. 中国慢性病预防与控制, 2022, 30(2): 81-86, 91. XIANG W Q, YU H, SU J, et al. Study on the Burden of Chronic Obstructive Pulmonary Disease and Smoking Attributed Disease Burden in People Aged 40 and Over in Jiangsu Province in 2015 and 2019[J]. China Chronic Disease Prevention and Control, 2022, 30(2): 81-86, 91.
[9]	LI H, LIANG H, WEI L, et al. Health inequality in the global burden of chronic obstructive pulmonary disease: findings from the Global Burden of Disease Study 2019[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17: 1695-1702. doi: 10.2147/COPD.S369120
[10]	BURGE P S, CALVERLEY P M, JONES P W, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial[J]. BMJ, 320(7245): 1297-303. DOI: 10.1136/bmj.320.7245.1297.
[11]	STOLBRINK M, THOMSON H, HADFIELD R M, et al. The availability, cost, and affordability of essential medicines for asthma and COPD in low-income and middle-income countries: a systematic review[J]. Lancet Glob Health, 2022, 10(10): e1423-e1442. doi: 10.1016/S2214-109X(22)00330-8
[12]	陈康勰, 黄耀光, 李辉, 等. 常用血常规指标对慢性阻塞性肺疾病急性加重的诊断价值[J]. 中国全科医学, 2020, 23(13): 4. CHEN K X, HUANG Y G, LI H, et al. The diagnostic value of commonly used blood routine indicators for acute exacerbation of chronic obstructive pulmonary disease[J]. Chinese General Practice, 2020, 23(13): 4.
[13]	陈亚红. 慢性阻塞性肺疾病急性加重的风险识别与早期干预[J]. 中华全科医师杂志, 2019, 18(3): 296-298. CHEN Y H. Risk identification and early intervention for acute exacerbation of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practitioners, 2019, 18(3): 296-298.
[14]	胡奕卿, 方继伟, 刘焕兵, 等. 肺功能检查技术如何在基层医疗卫生服务中更好地应用: 附重点问题专家解答[J]. 中国全科医学, 2023, 26(5): 532-536. HU Y Q, FANG J W, LIU H B, et al. How to better apply lung function testing technology in grassroots medical and health services-Expert answers to key questions[J]. Chinese General Practice, 2023, 26(5): 532-536.
[15]	彭博, 张小娟, 姜骁桐, 等. 基层医疗卫生机构慢性阻塞性肺疾病基本药物与诊断设备可获得性调查研究[J]. 中国全科医学, 2022, 25(7): 771-781. PENG B, ZHANG X J, JIANG X T, et al. A survey on the availability of essential drugs and diagnostic equipment for chronic obstructive pulmonary disease in primary healthcare institutions[J]. Chinese General Practice, 2022, 25(7): 771-781.
[16]	杨群娣, 苏秋云, 陈晓英, 等. 上海市社区卫生服务中心慢性阻塞性肺疾病防控能力分析[J]. 中华全科医学, 2023, 21(3): 442-444, 525. doi: 10.16766/j.cnki.issn.1674-4152.002903 YANG Q D, SU Q Y, CHEN X Y, et al. Analysis of the Prevention and Control Capability of Chronic Obstructive Pulmonary Disease in Shanghai Community Health Service Center[J]. Chinese Journal of General Practice, 2023, 21(3): 442-444, 525. doi: 10.16766/j.cnki.issn.1674-4152.002903
[17]	李凡, 盛春风, 王欢英. 提高全科医生在慢性病早期诊断和管理中的地位和作用: 以慢性阻塞性肺疾病为例[J]. 中国全科医学, 2021, 24(9): 1044-1050. LI F, SHENG C F, WANG H Y. Enhancing the Position and Role of General Practitioners in Early Diagnosis and Management of Chronic Diseases: A Case Study of Chronic Obstructive Pulmonary Disease[J]. Chinese General Practice, 2021, 24(9): 1044-1050.
[18]	逄慧, 潘子涵, 迟春花. 我国基层医疗卫生机构慢性阻塞性肺疾病呼吸康复的实施现状及展望[J]. 中华结核和呼吸杂志, 2021, 44(9): 828-833. PANG H, PAN Z H, CHI C H. Implementation status and prospects of respiratory rehabilitation for chronic obstructive pulmonary disease in primary healthcare institutions in China[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(9): 828-833.
[19]	翟文爽, 蔡汉炯, 钱佳, 等. 慢性阻塞性肺疾病患者家庭模式肺康复依从性变异曲线研究[J]. 中华全科医学, 2023, 21(7): 1157-1160, 1183. doi: 10.16766/j.cnki.issn.1674-4152.003073 ZHAI W S, CAI H J, QIAN J, et al. A study on the variation curve of family model pulmonary rehabilitation compliance in patients with chronic obstructive pulmonary disease[J]. Chinese Journal of General Practice, 2023, 21(7): 1157-1160, 1183. doi: 10.16766/j.cnki.issn.1674-4152.003073
[20]	高连军, 赵红梅. 2017年全国各级医疗机构医生对肺康复的认知及实施状况的调查[J]. 中华结核和呼吸杂志, 2019, 42(4): 275-278. GAO L J, ZHAO H M. A survey on the understanding and implementation of lung rehabilitation among doctors at all levels of medical institutions nationwide in 2017[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2019, 42(4): 275-278.
[21]	郝兴亮, 丁菊英, 王莹莹, 等. 理论与实践结合培训对基层医师慢性阻塞性肺疾病认知的影响[J]. 中华全科医师杂志, 2022, 21(5): 477-481. HAO X L, DING J Y, WANG Y Y, et al. The impact of theoretical and practical training on the cognition of chronic obstructive pulmonary disease among grassroots physicians[J]. Chinese Journal of General Practitioners, 2022, 21(5): 477-481.
[22]	陈明敏, 叶康丽, 徐志杰, 等. 我国慢性阻塞性肺疾病社区管理现状与展望[J]. 中国全科医学, 2020, 23(3): 251-256. CHEN M M, YE K L, XU Z J, et al. Current Status and Prospects of Community Management of Chronic Obstructive Pulmonary Disease in China[J]. Chinese General Practice, 2020, 23(3): 251-256.
[23]	陈婧瑜, 林修全, 章叶发, 等. 福建省40岁及以上居民慢性阻塞性肺疾病认知现状分析[J]. 慢性病学杂志, 2019, 20(3): 347-350. CHEN J Y, LIN X Q, ZHANG Y F, et al. Analysis of cognitive status of chronic obstructive pulmonary disease among residents aged 40 and above in Fujian Province[J]. Journal of Chronic Diseases, 2019, 20(3): 347-350.
[24]	CELLI B R, SINGH D, VOGELMEIER C, et al. New perspectives on chronic obstructive pulmonary disease[J]. Int J Chron Obstruct Pulmon Dis, 2022, 17: 2127-2136.
[25]	裴士杰, 阎刚, 邵强. 错失早期诊断时间与慢性阻塞性肺疾病严重程度的关系[J]. 国际呼吸杂志, 2023, 43(2): 229-234. PEI S J, YAN G, SHAO Q. The relationship between missed early diagnosis time and the severity of chronic obstructive pulmonary disease[J]. International Journal of Respiration, 2023, 43(2): 229-234.
[26]	YAWN B P, MARTINEZ F J. Point: can screening for COPD improve outcomes? Yes[J]. Chest, 2020, 157(1): 7-9. http://www.sciencedirect.com/science/article/pii/S0012369219312516
[27]	吴建忠, 黄可, 雷洁萍, 等. "中国县域慢阻肺管理中心"项目慢性阻塞性肺疾病高危人群筛查及危险因素分析[J]. 国际呼吸杂志, 2022, 42(12): 917-921. WU J Z, HUANG K, LEI J P, et al. Screening and risk factor analysis of high-risk population for chronic obstructive pulmonary disease in the "China County Chronic Obstructive Pulmonary Disease Management Center" project[J]. International Journal of Respiration, 2022, 42(12): 917-921.
[28]	中华医学会呼吸病学分会慢性阻塞性肺疾病学组, 中国医师协会呼吸医师分会慢性阻塞性肺疾病工作委员会. 慢性阻塞性肺疾病诊治指南(2021年修订版)[J]. 中华结核和呼吸杂志, 2021, 44(3): 170-205. Chronic Obstructive Pulmonary Disease Group of the Respiratory Branch of the Chinese Medical Association, Chronic Obstructive Pulmonary Disease Working Committee of the Respiratory Branch of the Chinese Medical Association. Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (Revised in 2021)[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2021, 44(3): 170-205.
[29]	王凤燕, 张冬莹, 梁振宇, 等. 面向全科医生的《慢性阻塞性肺疾病诊治指南(2021年修订版)》解读[J]. 中国全科医学, 2021, 24(29): 3660-3663, 3677. WANG F Y, ZHANG D Y, LIANG Z Y, et al. Interpretation of the Diagnosis and Treatment Guidelines for Chronic Obstructive Pulmonary Disease (2021 Revised Edition) for General Practitioners[J]. Chinese General Practice, 2021, 24(29): 3660-3663, 3677.
[30]	王熙龙, 梁振宇, 张海云, 等. 慢性阻塞性肺疾病防控新视角: 慢阻肺前期人群的多维度思考[J]. 国际呼吸杂志, 2023, 43(2): 150-154. WANG X L, LIANG Z Y, ZHANG H Y, et al. A New Perspective on the Prevention and Control of Chronic Obstructive Pulmonary Disease: Multidimensional Thinking of the Pre COPD Population[J]. International Journal of Respiration, 2023, 43(2): 150-154.
[31]	梁振宇, 王凤燕, 陈子正, 等. 2023年GOLD慢性阻塞性肺疾病诊断、管理及预防全球策略更新要点解读[J]. 中国全科医学, 2023, 26(11): 1287-1298. LIANG Z Y, WANG F Y, CHEN Z Z, et al. Interpretation of the Key Points of the Global Strategy Update for Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease by GOLD in 2023[J]. Chinese General Practice, 2023, 26(11): 1287-1298.
[32]	潘明鸣, 李燕明. 提高慢性阻塞性肺疾病患者疫苗接种率: 从临床医师做起[J]. 中华结核和呼吸杂志, 2022, 45(4): 335-338. PAN M M, LI Y M. Improving the vaccination rate of patients with chronic obstructive pulmonary disease: Starting from clinical physicians[J]. Chinese Journal of Tuberculosis and Respiratory Diseases, 2022, 45(4): 335-338.
[33]	吕梦轩, 祁祯楠, 迟春花. 基于可穿戴设备的智慧医疗对慢性阻塞性肺疾病管理的影响[J]. 中华全科医师杂志, 2022, 21(3): 213-218. LYU M X, QI Z N, CHI C H. The impact of smart healthcare based on wearable devices on the management of chronic obstructive pulmonary disease[J]. Chinese Journal of General Practitioners, 2022, 21(3): 213-218.